Treatment and outcomes of primary urethral cancer
Asian J Surg
.
2022 Sep;45(9):1726-1727.
doi: 10.1016/j.asjsur.2022.01.014.
Epub 2022 Feb 11.
Authors
Shujun Yang
1
,
Shun Wan
1
,
Duo Zheng
2
,
Yongsheng Yin
3
,
Weiping Li
4
,
Panfeng Shang
5
Affiliations
1
Department of Urology, Lanzhou University Second Hospital, Lanzhou 730000, China.
2
Department of Urology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
3
Department of Urology, Gansu Provincial People's Hospital, Lanzhou 730000, China.
4
Department of Urology, Chinese People's Liberation Army Joint Logistics Support Unit 940 Hospital, Lanzhou 730000, China.
5
Department of Urology, Lanzhou University Second Hospital, Lanzhou 730000, China. Electronic address: shangpf@lzu.edu.cn.
PMID:
35165024
DOI:
10.1016/j.asjsur.2022.01.014
No abstract available
Keywords:
Pathology; Primary urethral cancer; Treatment.
Publication types
Letter
MeSH terms
Humans
Retrospective Studies
Treatment Outcome
Urethra / surgery
Urethral Neoplasms* / surgery